The Chemours Co (CC) posted 3% sales growth and $200 million in adjusted EBITDA at the high end of guidance, while raising TiO2 prices 10% and expanding AI infrastructure exposure to 10% of sales.
Detailed price information for Chemours Company (CC-N) from The Globe and Mail including charting and trades.
Chemours is upgraded to a buy after a 27% drop, with valuation now compelling and downside risks priced in. Read more on CC stock here.
(CC) on Monday reported third-quarter net income of $196 million.The Wilmington, Delaware-based company said it had profit of $1.
Detailed price information for Chemours Company (CC-N) from The Globe and Mail including charting and trades.
Detailed price information for Chemours Company (CC-N) from The Globe and Mail including charting and trades.
Notice: Speculative, but getting very interesting here given the previously proven upsideIn this article, I'll be updating my case on Chemours (CC).
Analysts downgraded CTNM, CC, ACI, BRKR and SAFE; targets fell for CTNM, CC and ACI, while BRKR received a new $60 target.
Chemours (NYSE:CC) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire
This is the newest page. Registered accounts read further back.